Suppr超能文献

C反应蛋白与淋巴细胞比值作为预测后路腰椎椎间融合术及内固定术后手术部位感染的新型生物标志物。

C-reactive protein to lymphocyte ratio as a new biomarker in predicting surgical site infection after posterior lumbar interbody fusion and instrumentation.

作者信息

Wu Xiaofei, Ma Xun, Zhu Jian, Chen Chen

机构信息

Department of Orthopaedic Surgery, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.

Department of Orthopaedic Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.

出版信息

Front Surg. 2022 Oct 4;9:910222. doi: 10.3389/fsurg.2022.910222. eCollection 2022.

Abstract

PURPOSE

This study aims to evaluate the potential of C-reactive protein to lymphocyte count ratio (CLR) for the prediction of surgical site infection (SSI) following posterior lumbar interbody fusion (PLIF) and the instrumentation of lumbar degenerative diseases.

METHODS

In this retrospective study, we considered patients with a lumbar degenerative disease diagnosis surgically treated by the instrumented PLIF procedure from 2015 to 2021. Patient data, including postoperative early SSI and other perioperative variables, were collected from their respective hospitalization electronic medical records. The receiver operator characteristic curve was constructed to determine the optimal cut-off value for CLR, and the ability to predict SSI was evaluated by the area under the curve (AUC). According to the cut-off value, patients were dichotomized with high- or low-CLR, and between-group differences were compared using univariate analysis. The independent impact of CLR on predicting SSI was investigated by multivariate logistics regression analysis.

RESULTS

A total of 773 patients were included, with 26 (3.4%) developing an early SSI post-operation. The preoperative CLR was 11.1 ± 26.1 (interquartile range, 0.4-7.5), and the optimal cut-off was 2.1, corresponding to a sensitivity of 0.856, a specificity of 0.643, and an AUC of 0.768 (95% CI, 0.737-0.797). CLR demonstrated a significantly improved prediction ability than did lymphocyte count (= 0.021) and a similar ability to predict an infection as C-response protein ( = 0.444). Patients with a high CLR had a significantly higher SSI incidence than those with a low CLR (7.6% vs. 0.8%, < 0.001). After adjustment for numerous confounding factors, CLR ≥ 2.1 was associated with an 11.16-fold increased risk of SSI, along with other significant variables, i.e., diabetes, preoperative waiting time, and surgical duration.

CONCLUSION

A high CLR exhibited an improved ability to predict incident SSI and was associated with a substantially increased risk of SSI following instrumented PLIF. After better-design studies verified this finding, CLR could potentially be a beneficial tool in surgical management.

摘要

目的

本研究旨在评估C反应蛋白与淋巴细胞计数比值(CLR)预测后路腰椎椎间融合术(PLIF)及腰椎退行性疾病内固定术后手术部位感染(SSI)的潜力。

方法

在这项回顾性研究中,我们纳入了2015年至2021年期间接受器械辅助PLIF手术治疗的腰椎退行性疾病患者。从各自的住院电子病历中收集患者数据,包括术后早期SSI及其他围手术期变量。构建受试者工作特征曲线以确定CLR的最佳截断值,并通过曲线下面积(AUC)评估其预测SSI的能力。根据截断值,将患者分为高CLR组和低CLR组,采用单因素分析比较组间差异。通过多因素logistic回归分析研究CLR对预测SSI的独立影响。

结果

共纳入773例患者,其中26例(3.4%)术后发生早期SSI。术前CLR为11.1±26.1(四分位间距,0.4 - 7.5),最佳截断值为2.1,对应敏感度为0.856,特异度为0.643,AUC为0.768(95%CI,0.737 - 0.797)。CLR显示出比淋巴细胞计数(P = 0.021)显著更好的预测能力,且与C反应蛋白预测感染的能力相似(P = 0.444)。高CLR患者的SSI发生率显著高于低CLR患者(7.6%对0.8%,P < 0.001)。在调整众多混杂因素后,CLR≥2.1与SSI风险增加11.16倍相关,同时还与其他显著变量相关,即糖尿病、术前等待时间和手术时长。

结论

高CLR表现出更好的预测SSI发生的能力,且与器械辅助PLIF术后SSI风险大幅增加相关。在经过设计更优的研究验证这一发现后,CLR可能成为手术管理中的一个有益工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42b3/9577359/d1a1ce16b9c5/fsurg-09-910222-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验